In this study the syntheses of 11 novel lignans are described. Their cytotoxicities are studied in GLC 4 , a human small cell lung carcinoma cell line, using the microculture tetrazolium (MTT) assay. Ten of these compounds were substituted with a menthyloxy group on the 5-position of the lactone. These compounds can easily be prepared in (novel) 'one-pot', three-or four-step syntheses. In addition, methods for controlling the stereogenic centers are described. Furthermore, five naturally occurring podophyllotoxin-related compounds were tested. The cytotoxicities of all lignan compounds, and of three non-lignan intermediates originating from the syntheses, were compared with the clinically applied anticancer agents etoposide, teniposide, and cisplatin. Most compounds showed moderate to high activities against GLC 4 , and two of the compounds containing a menthyloxy group showed activities comparable to the reference cytotoxic agents.
Introduction
Lignans form an important class of compounds that are being applied in cancer chemotherapy. There is a demonstrated need of novel anticancer agents, and these can be found among lignan-related structures. These compounds can be investigated either by isolating lignans from plant material, which can be followed by (semisynthetic) derivatization, or by total synthesis. In this study the structure-activity relationships (SAR) among a range of naturally occurring lignans, 1 synthetically prepared lignans, 2 intermediates from these syntheses, and semisynthetic derivatives obtained from naturally occurring lignans have been investigated. 3 The compounds for SAR-investigation (Table 1) were divided into four groups in which structural elements were altered, (a) removal or addition of the benzyl-, ethoxyethyl-, 1,3-propyldithiane-, thiophenyl-, and methylenedioxy-protective groups, (b) removal or alteration of the menthyloxy group, (c) podophyllotoxin-like compounds, and (d) non-lignan compounds synthesized for assignment of the stereogenic centers of the lignan compounds. The cytotoxicity of these compounds was evaluated in GLC 4 , 4 a human small cell lung carcinoma cell line, using the microculture tetrazolium (MTT) assay. 5 The GLC 4 cell line was used because etoposide (VP- and teniposide (VM-26), two clinically applied anticancer agents that are semisynthetic derivatives of podophyllotoxin, 6 are known to be particularly active against small cell lung tumors. These two compounds induce double-stranded DNA breaks by inhibiting the topoisomerase II repair system. In contrast, podophyllotoxin and deoxypodophyllotoxin are known to act as antimitotic spindle poisons. By binding to tubulin, these compounds inhibit microtubule formation.
The total syntheses of 5-methoxypodophyllotoxin (1), (-)-pluviatolide 2 (2) , and (-)-hinokinin 2 (3) (Figure 1 ) yielded several lignans and lignan intermediates which are based structurally on l-menthol. These compounds are biologically interesting because a large menthyloxy group might block the binding to tubulin. Our first aim was to study whether the compounds containing a menthyloxy group at the lactone segment might exhibit promising cytotoxic activity. In addition, to enlarge the scope of this study, other related podophyllotoxin-like compounds were isolated from Podophyllum hexandrum Royle and Linum flavum L. 1 or synthesized from podophyllotoxin. 3 As reference compounds the clinically applied anticancer agents etoposide, teniposide, and cisplatin were used.
Chemistry
A Michael addition in dry tetrahydrofuran (THF), using (5R)-(l-menthyloxy)-2(5H)-furanone (5) as a Michael acceptor and freshly prepared lithiated dithianes 4 as Michael donors, yielded lithium enolate 6 (Scheme 1). Lignans could then be obtained in two different ways. Quenching this enolate with the appropriate benzylic bromides yielded the lignan compounds 7-9 2 under conditions providing total control of all stereogenic centers. Reaction of the enolate formed after a Michael addition with the appropriate benzaldehydes yielded the lignan compounds 10 and 11. The desired stereochemistry at the hydroxyl functionality formed during the aldol condensation was achieved by transmetalation of the lithium enolate 6 to the boron 7 or titanium 8 enolates (Scheme 1). Using this method, one of the π-faces is effectively shielded so that only the syn-product can be formed in the condensation reaction with an aldehyde. In the synthesis of compound 11, compound 12 (Table  1) was isolated as a side product (11%).
Hydrolysis of the thioketal functionality in compound 10 was accomplished using mercury(II) chloride in aqueous acetonitrile; 9 compound 13 was obtained. Protection of the C6-hydroxyl functionality of compounds 10 and 13 with an ethoxyethyl group provided compounds 14 and 15, respectively. Protection was accomplished by reaction with vinyl ethyl ether and a catalytic amount of toluene sulfonic acid in dry toluene.
Reduction of the thioketal in compound 9 was performed with Raney nickel 2a in THF, to provide compound 16. Reduction of the thioketal in compound 8 was performed in methanol with 'Ni 2 B' generated in situ from NiCl 2 and NaBH 4 . Removal of the benzyl-protective group provided compound 2. The reduction of the ketal moiety in compound 8, with removal of the chiral auxiliary, was accomplished by adding aqueous potassium hydroxide and sodium borohydride to this reaction mixture. After acidic workup and subsequent deprotection of the 4´-hydroxyl functionality using palladiumblack under a hydrogen atmosphere, (-)-pluviatolide (2) was obtained. (5R)-(l-Menthyloxy)-2(5H)-furanone (5) was also used for the synthesis of (-)-hinokinin (3). An analogous procedure using 5-methoxy-2(5H)-furanone yielded compound 18.
2b
The total syntheses yielded several other lactones (24-26; Table 1 ). Using the same procedures as those used for the Michael additions in the previously described lignan syntheses, the enolate anion 6 was quenched with an aqueous ammonium chloride solution to give the monobenzylated furanone. These compounds enabled us to prove the antiselectivity of the Michael additions by two-dimensional 1 H NMR, the transrelationship between the substituents at C4 and C5 of the lactone could easily be determined by the small coupling constant (J < 2 Hz). The trans-stereochemistry at the C3 stereocenter at the lactone ring was easily deduced from 1 H NMR and, in one case, confirmed by X-ray analysis as described previously.
2c Assignment of the stereochemistry of the fourth exocyclic stereogenic center, which was formed during the aldol condensation, was more difficult because no NOE effect was observed in two-dimensional NMR for this proton; this is consistent with the stereochemistry indicated, but it is not absolute proof. For crystalline compounds, the stereochemistry of this stereogenic center can be assigned unambiguously, using X-ray crystallography, as described by Jansen. (Linaceae), and 4´-demethylpodophyllotoxin (21) was isolated from cell cultures of P. hexandrum Royle 3 (Berberidaceae). Podophyllotoxin glucoside (19) was synthesized following procedures that have been described for the syntheses of etoposide and teniposide. 6 The compounds described above are summarized in Table 1 .
Biological Results
Biological results are listed in Table 2 . For the structural formulas, see Table 1 . Comparing the cytotoxic effects of compounds within the structural groups a-d (see Introduction), based on continuous as well as 2 h incubation, some general effects were observed with respect to the chemical structures and their substituents. These are summarized below. R 1 . Removal of the methylenedioxy group of compound 11 to give 12, resulting in two free hydroxyl groups, significantly enhanced the activity following continuous incubation. If methoxy groups were intro- duced instead of a methylenedioxy group (7 versus 16), no significant difference in cytotoxicity was observed. R 2 . Compounds with a carbonyl functionality at C7 showed the highest cytotoxicity (13, 15) . Replacing a carbonyl by a dithiane reduced the activity against GLC 4 (p < 0.05, 13 versus 10 and 15 versus 14). Further enlargement of the dithiane moiety reduced activity (compare Table 1 , parts a and b). Cytotoxic effects comparable to etoposide, teniposide, and cisplatin were observed for compounds 13 and 15. Comparing these results with How a free hydroxyl group at the benzylic position (10-13) influences cytotoxicity cannot be concluded from our experiments. On the other hand, protecting the hydroxyl functionality with an ethoxyethyl group significantly enhanced the activity found in 2 h incubations (compare 10 to 14 and 13 to 15). Following continuous incubation, however, this effect was less pronounced or even absent. Ring-closed podophyllotoxin-like structures (20-23) showed the highest cytotoxic effects (Table 1c) . R 4 . Compared to a methoxy group, a benzyl group at R 4 reduced the activity (p < 0.05, 10 compared to 11). Within the range of podophyllotoxin-like compounds (20 and 21), a free hydroxyl compared to a methoxy substituent at C4´ (Figure 1 ), significantly reduced the activity after a 2 h incubation period. In continuous incubation it slightly enhanced the activity. R 5 . Introduction of a methylenedioxy functionality instead of a methoxy substituent did not lead to significant differences in cytotoxicity. Compounds 7 and 16 showed similar activities. R 6 . A compound containing a methoxy group showed a much higher IC 50 value than one with a menthyloxy group (p < 0.05, 18 versus 9), indicating that a menthyloxy group at this position could enhance the activity. From our experiments the possible effects of removing the menthyl group cannot be deduced. R 7 . A methoxy substituent at R 7 did not significantly influence the activity (25 versus 26). Podophyllotoxin (20) and 5-methoxypodophyllotoxin (1) showed comparable cytotoxicities.
The results of this study are summarized in the Table  3 in which the structural elements are arranged in order of their influence on the activities.
Discussion
Compounds 10 and 11 were synthesized in a novel, 2 'one-pot' four-step synthesis. These kinds of compounds would normally be prepared step by step. The large advantage of this approach is that these compounds can now readily be synthesized within 1 day, with total control of all stereogenic centers. Purification steps take less time because all starting materials can now easily be removed by flash chromatography, and purification of the products can be carried out by column chromatography. Synthesizing these compounds step by step can imply a number of purification steps, which in some cases can be a real problem as described in this paper for compound 25. From Table 2 it can be seen that for several compounds (2, 10, 12, 21) a very large difference in cytotoxicity was found between 2 h and continuous incubation. These differences may be explained in terms of the structure of these compounds. Probably the substituents are too bulky, or possess a low-lipophilic character, resulting in low intracellular concentration after 2 h exposure. Increasing cytotoxicity has been found with increasing lipophilicity. 10 The difference in cytotoxicity (continuous incubation) between a compound with a methoxy group and compounds with a menthyloxy group (9 versus 18) could also be explained in terms of different lipophilicities. The benzyl substituent in compounds 8 and 11 seems to be too bulky; although these compounds possess a more lipophilic character, their cytotoxic effect is reduced compared to compounds with a methoxy substituent at this position (10, 13-15). The more bulky phenyldithianes (8, 9, 18) showed lower cytotoxic effects compared to the less bulky propyldithianes (10) (11) (12) 14) .
From our study it may be concluded that some structural elements influence the cytotoxicity. An ethoxyethyl group (14, 15 compared to 10, 13), a carbonyl (13, 15 compared to 10, 14) , a free hydroxyl (12, 16) , and ring closure (20-23) enhanced cytotoxicity within our range of lignan compounds. A benzylprotective group (11, 15) and dithiane-protective groups (10, 14, 18 versus 13, 15, 2) seemed to reduce the cytotoxic effects.
On the basis of IC 50 values, deoxypodophyllotoxin (23) was about 8 times more toxic than podophyllotoxin (20) in continuous incubations, in contrast to the difference of a factor of only 2 times found in 2 h incubations. The difference in biological activity as found in our study is not in agreement with earlier SAR studies carried out with podophyllotoxin, 11 in which it was concluded that the free hydroxyl at C7 is partially responsible for the binding to tubulin. Both compounds are known to act as antimitotic spindle poisons.
Compounds 13 and 15 showed activities to GLC 4 in the same range as etoposide, teniposide, and cisplatin. Whether their cytotoxicity is a result of binding to the enzyme topoisomerase II, which is essential in the DNA breakage-reunion process, or whether they act as spindle poisons by binding to tubulin is not clear from our experiments. Further studies should reveal whether one of the substituents (for instance a menthyloxy group) is able to block the binding to tubulin. Compounds 13 and 15 are the most interesting of the synthesized compounds based upon their IC 50 values.
Experimental Section
Cell Line. GLC 4 , a human small cell lung carcinoma cell line, was derived from a pleural effusion at the Department of Internal Medicine, University Hospital Groningen, The Netherlands. 4 This cell line grows in suspension culture, partly floating and partly attached, in RPMI 1640 medium (Gibco, Paisly, U.K.), supplemented with 10% heat-inactivated (30 min, 56 °C) fetal calf serum (Gibco) plus 50 µg/mL streptomycin and 50 IU/mL penicillin. It was maintained at 37°C in a humidified atmosphere with 5% CO 2 . The doubling time was 18-21 h. Cells were in the exponential phase of growth at the moment of testing the compounds. The viability of the cells used in the experiments exceeded 90% as determined with trypan blue.
Cytotoxicity Assay. Cytotoxicity after treatment of the tumor cells with the test compounds was determined using the microculture tetrazolium (MTT) assay. 5 This assay is based on the reduction of a soluble tetrazolium salt by mitochondrial dehydrogenase activity of viable tumor cells to an insoluble, colored formazan product.
The amount of this formazan product can be measured spectrophotometrically after dissolution 10 in dimethyl sulfoxide (Merck, Darmstadt, FRG). Under the experimental conditions used in the present study, the enzyme activity and the amount of formazan formed were proportional to the amount of cells. Reduction in the amount of cells by a particular agent can generally be explained by killing of cells and/or inhibition of cell proliferation.
Concentrated stock solutions (200 × ) were made in dimethyl sulfoxide and stored at -20 °C. Exponentially growing cells were harvested. The cell suspension was diluted appropriately with RPMI 1640 medium plus 10% fetal calf serum. Of this cell suspension, 50 µL containing 3750 cells was pipetted into 96-well micro titer plates (Nunc, Roskilde, DK).
Subsequently, 50 µL of a solution of the test compounds, obtained by diluting the stocks with RPMI 1640 medium plus 10% fetal calf serum, was added to each well. The small amount of dimethyl sulfoxide present in the wells (maximum 0.25%) proved not to affect the experiments. The highest concentration of the compounds tested was 100 µM.
The cells were exposed to the test compounds either continuously (4 days) or for 2 h. Only compounds with an IC 50 ≤ 10 µM following continuous exposure were used for the 2 h incubations. After the 2 h exposure period at 37 °C in a humidified atmosphere with 5% CO 2 , the cells were washed three times with 200 µL of culture medium (10 min, 20 °C, 210g). After the washing steps, the plates were incubated in the same atmosphere for a culture period of 4 days.
A 5 mg/mL solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St, Louis, MO) was prepared in phosphate-buffered saline (PBS; 1.5 mM KH 2 PO 4 , 6.5 mM Na 2 HPO 4 , 137 mM NaCl, 2.7 mM KCl; pH 7.4). Of this solution, 20 µL was pipetted into each well. Following an incubation time of 3 h 45 min with MTT at 37 °C in a humidified atmosphere with 5% CO 2 and centrifugation of the plates (15 min, 20 °C, 210g), the medium was carefully aspirated. The formazan product formed was then dissolved in 200 µL of dimethyl sulfoxide. After thorough mixing, the absorbance was measured at 520 nm using a scanning microtiterwell spectrophotometer (Titertek Multiscan; Flow Laboratories, Irvine, U.K. relative to TMS (δ = 0 ppm), and signal multiplicity was designated according to the following abbreviations: s, singlet; d, doublet; t, triplet; q, quartet; br, broad singlet; m, multiplet. HRMS spectra were recorded on a AEI MS-902 spectrometer (EI). Melting points were determined on a Mettler FP-2 (uncorrected). Optical rotations were measured at the Na D-line on a Perkin Elmer 241 MC instrument at room temperature. Chloroform was used as a solvent. Chromatography was performed using silica gel 60 F 254 (Merck, Art. No. 7734 or 9385). R f values were determined on TLC plates precoated with 0.25 mm thick silica gel 60 F 254 (Merck Art. No. 5714). Unless otherwise noted, R f = 0.3 for compounds purified by chromatography. Solvents were purified using standard procedures. (5R)-(l-Menthyloxy)-2(5H)-furanone (5) was synthesized according to a procedure previously described by de Jong and Feringa. 12 2-Methoxy-3,4-(methylenedioxy)-benzaldehyde was synthesized according to a procedure described by Baker et al. 13 Chlorotitanium tris(diethylamide) was freshly prepared as described by Reetz and Urz. 8 Ethylene chloroboronate was synthesized following a procedure described Hoffmann and Dittrich. 14 3,4,5-Trimethoxybenzaldehyde, podophyllotoxin, and syringaldehyde were purchased from Janssen Chimica (Beerse, Belgium). Compound 20 was synthesized according to a procedure described in the literature. 15 Syringaldehyde was benzylated using a procedure described by Loirot et al. 16 The syntheses of compounds 7-9 and 16-18 have been described elsewhere (protocols and analyses). 2 Isolation procedures for compounds 20-22 also have been described elsewhere. 1 Reactions that were sensitive to air and moisture were carried out under nitrogen atmosphere using flame-dried glassware.
1,2-(Methylenedioxy)-3-methoxy-4-[(1,3-propylenedithio)methyl]benzene (4). To a solution of 2-methoxy-3,4-
(methylenedioxy)benzaldehyde (12 g, 80 mmol) in toluene (80 mL) were added 1,3-propanedithiol (6.1 g, 80 mmol) and toluenesulfonic acid (0.1 g, catalytic amount). The reaction was carried out overnight with azeotropic removal of water. The solvent was removed in vacuo and the residue redissolved in chloroform (50 mL). The organic layer was washed with water (100 mL) subsequently and twice with 1 N NaOH and dried over magnesium sulfate. Removal of the solvent under reduced presure yielded a yellowish colored oil, which was recrystallized from THF-hexane to provide colorless cubic crystals of the pure 1,3-propyldithiane of 2-methoxy-3,4-(methylenedioxy)benzaldehyde (4) Table 1a) . To a solution of 4 (1.12 g, 4.16 mmol) in dry THF (40 mL) at -78 °C was added n-BuLi (2.00 mL, 2.5 M, in hexane, 5 mmol) dropwise within a period of 30 min. Stirring was continued for 30 min, and then a solution of (5R)-(l-menthyloxy)-2(5H)-furanone (5) (1.00 g, 4.58 mmol) in THF (5 mL) was added dropwise over a period of 20 min at -90 °C. The orange-brown lithium enolate solution of 6 was used as such in further syntheses.
General Procedure for the Formation of the Enolate; Michael Addition of Lithiated 4 to (5R)-(l-Menthyloxy)-2(5H)-furanone (5) (
General Procedure for Transmetalation to the Titanium and Boron Enolates (Table 1a) . At -90 °C chlorotitanium tris(diethylamide) 8 (4.0 mL, 12.6 mmol) was added to the lithium enolate solution. The temperature was allowed to rise to -45 °C over a period of 40 min, resulting in the formation of the dark red titanium enolate solution. This solution was used as such in further syntheses.
At -50 °C ethylene chloroboronate (1.0 g, 9.4 mmol) was added to the lithium enolate solution. The temperature was allowed to rise to -15 °C over a period of 1 h; this resulted in the formation of the brightly yellow boron enolate solution.
( (3R,4R,5R) 4-[[2-methoxy-3,4-(methylenedioxy)phenyl]-oxomethyl]-5-(l-menthyloxy)dihydro-2(3H)-furanone (13) . To a stirred solution of 10 (190 mg, 0.273 mmol) in acetonitrile/ acetone/water, volume ratio 6:3:2.2 at room temperature, HgCl 2 (289 mg, 0.612 mmol) and CaCO 3 (114 mg, 1.139 mmol) were added. Reaction was followed on TLC (diethyl ether/ hexane, 2:1) and was complete after about 30 min. Subsequently, the reaction mixture was filtered and extracted with dichloromethane (50 mL). The organic layer was washed with water (2 × 30 mL) and brine (30 mL). Column chromatography with diethyl ether/hexane (3:2) yielded compound 13, 89 mg (0.147 mmol, 67%), as a colorless oil, which colorizes upon standing. This compound had to be repurified (column chromatography; diethyl ether/hexane, 3:2) before it could be used in cytotoxicity experiments: 1 To a stirred solution of 24 (3.53 g, 7.11 mmol) in EtOH (absolute) was added sodium borohydride (2.02 g, 53.5 mmol). Subsequently, KOH (0.81 g, 14.4 mmol) was added at once, and stirring was continued for 1 h. The reaction mixture was acidified to pH 4.0 with 1 N HCl and extracted with diethyl ether. Compound 4 was the side product of this reaction, and we were not able to find a successful purification method. Only a small amount of 25 was isolated ( <1%): 1 (16) .
Deoxypodophyllotoxin (23). Podophyllotoxin (1.3 g, 3.05 mmol) was dissolved in 70 mL of acetic acid, and 1.0 g of palladium (10%) on carbon was added. Podophyllotoxin was reduced under an atmosphere of hydrogen at 95 °C during 48 h with stirring. Subsequently the reaction mixture was filtered, and ca. 100 mL of diethyl ether was added to the clear solution. 67 (s, 1 H, C5-H), 6.52 (s, 1 H, C2-H), 6.35 (s, 2 H,   H-2´ and H-6´), 5.95 (d, 1 H, J = 1.3 Hz, C10-H), 5.93 (d, 1 H, 
